Hypercoagulability in patients undergoing coronary artery bypass grafting: Prevalence, patient characteristics and postoperative outcome

European Journal of Cardio-thoracic Surgery

Volumn 41, Issue 3, 2012, Pages 550-555

  Rafiq, Sulman ^a   Johansson, Pär Ingemar ^a   Ostrowsk, Sisse Rye ^a   Stissing, Trine ^a  

^a Rigshospitalet   (Denmark)

Author keywords

CABG; Hypercoagulability; TEG; Thromboelastography; Thromboembolic

Indexed keywords

FIBRINOGEN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE ASSOCIATION; FEMALE; GENDER; HEART INFARCTION; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY; TREATMENT OUTCOME; BLOOD SAMPLING; METHODOLOGY; MIDDLE AGED; PREOPERATIVE PERIOD; RISK FACTOR; STROKE; THROMBOPHILIA;

AGED; BLOOD SPECIMEN COLLECTION; CORONARY ARTERY BYPASS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREOPERATIVE PERIOD; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; THROMBELASTOGRAPHY; THROMBOPHILIA; TREATMENT OUTCOME;

EID: 84861452047     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezr001     Document Type: Article

References (17)

1. Mccrath DJ, Cerboni E, Frumento RJ, Hirsh AL, Bennett-Guerrero E. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005;100:1576-83.
2. Gurbel PA, Bliden KP, Guyer K, Cho PW, Zaman KA, Kreutz RP et al. Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING study. J Am Coll Cardiol 2005;46: 1820-6.
3. Kashuk JL, Moore EE, Sabel A, Barnett C, Haenel J, Le T et al. Rapid thromboelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients. Surgery 2009;146: 764-74.
4. Bochsen L, Nielsen AB, Steinbrüchel DA, Johansson PI. Higher throm-boelastograph platelet reactivity in cardiac surgery patients than in blood donors. Scand Cardiovascular J 2007;41:321-4.
5. Gurbel PA, Bliden KP, Kreutz RP, Dichiara J, Antonino MJ, Tantry US. The link between heightened thrombogenicity and inflammation: pre-procedure characterization of the patient at high risk for recurrent events after stenting. Platelets 2009;20:97-104.
6. Chen A, Teruya J. Global hemostasis testing thromboelastography: old technology, new applications. Clin Lab Med 2009;29:391-407.
7. Attaran S, Somov P, Awad WI. Randomised high-and low-dose heparin prophylaxis in patients undergoing thoracotomy for benign and malignant disease: effect on thrombo-elastography. Eur J Cardiothorac Surg 2010;37:1384-90.
8. Nashef SA, Roques F, Hammil BG, Peterson ED, Michel P, Grover FL et al.. Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg 2002;22:101-5.
9. Roeloffzen WH, Kluin-Nelemans HC, Mulder AB, Vaeger NJ, Bosman L, de Wolf JT. In normal controls, both age and gender affect coagulability as measured by thromboelastography. Anesth Analg 2010; 110:987-94.
10. Theusinger OM, Nürnberg J, Asmis LA, Seifert B, Spahn DR. Rotation thromboelastometry (ROTEM®) stability and reproducibility over time. Eur J Cardiothorac Surg 2010;37:677-83.
11. Devaraj S, Siegel D, Jialal I. Statin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP? Curr Atheroscler Rep 2011;13:31-42.
12. Song CJ, Nakagomi A, Chandar S, Cai H, Lim IG, McNeil HP et al C-reactive protein contributes to the hypercoagulable state in coronary artery disease. J Thromb Haemost 2006;4:98-106.
13. Tantry US, Bliden KP, Suarez TA, Kreutz RP, Dichiara J, Gurbel PA. Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: results of the thrombotic risk progression (TRIP) study. Platelets 2010;21:360-7.
14. Kulik A, Chan V, Ruel M. Antiplatelet therapy after coronary artery bypass graft surgery: perioperative safety and efficacy. Opin Drug Saf 2009;8:169-82.
15. Mehta SR, Yusuf S, Peters RJ. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;18;358: 527-33.
16. Squizzato A, Keller T, Middledorp S. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease. Cochrane database of systemic reviews 2007, Issue 3, Art. No. CD005158. DOI:10.1002/14651858.CD005158.pub2.
17. Taggart DP, Boyle R, de Belder MA. The 2010 ESC/EACTS Guidelines on Myocardial Revascularisation. Eur J Cardiothorac Surg 2010;38: S1-52.